INSMED INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INSMED INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-12-31 was 66.62K shares, a 58.10% increase year-over-year.
- INSMED INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-09-30 was 46.36K shares, a 32.61% decline year-over-year.
- INSMED INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-06-30 was 368.74K shares, a 84.93% increase year-over-year.
- INSMED INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-03-31 was 12.63K shares, a 81.41% decline year-over-year.
- INSMED INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 5.60M shares, a 16.29% increase from fiscal 2024.
- INSMED INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 4.81M shares, a 452.03% increase from fiscal 2023.
- INSMED INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 871.93K shares, a 24.27% decline from fiscal 2022.
- INSMED INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 1.15M shares, a 6.79% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 5.60M shares 10-K · filed 2026-02-19 | |
| 2024-12-31 | 4.81M shares 10-K · filed 2025-02-20 | |
| 2023-12-31 | 871.93K shares 10-K · filed 2025-02-20 | |
| 2022-12-31 | 1.15M shares 10-K · filed 2025-02-20 | |
| 2021-12-31 | 1.24M shares 10-K · filed 2024-02-22 | |
| 2020-12-31 | 1.68M shares 10-K · filed 2023-02-23 | |
| 2019-12-31 | 1.41M shares 10-K · filed 2022-02-17 | |
| 2018-12-31 | 66.62K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 494.35K shares 10-K · filed 2021-02-25 |
| 2018-09-30 | 46.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | 469.87K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | 368.74K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 492.31K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | 12.63K shares 10-Q · filed 2018-05-02 | 322.96K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | 42.14K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | 378.27K shares 10-K · filed 2020-02-25 |
| 2017-09-30 | 68.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | 478.12K shares derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | 199.39K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 409.32K shares derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | 67.94K shares 10-Q · filed 2017-05-03 | 214.97K shares derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | 141.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | 162.34K shares 10-K · filed 2019-02-22 |
| 2016-09-30 | 0.00 shares 10-Q · filed 2016-11-03 | 30.36K shares derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | 5.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 90.22K shares derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | 15.31K shares 10-Q · filed 2016-05-05 | 318.38K shares derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | 481.14K shares 10-K · filed 2018-02-23 |
| 2015-09-30 | 59.86K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | 600.25K shares derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | 233.21K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 634.55K shares derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | 178.07K shares 10-Q · filed 2015-05-07 | 408.73K shares derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | 129.11K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | 283.06K shares 10-K · filed 2017-02-23 |
| 2014-09-30 | 94.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | 181.77K shares derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | 7.39K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | 284.00K shares derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | 52.40K shares 10-Q · filed 2014-05-08 | 406.97K shares derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | 27.82K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | 371.74K shares 10-K · filed 2016-02-25 |
| 2013-09-30 | 196.38K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | 374.17K shares derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | 130.36K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | 177.78K shares derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | 17.17K shares 10-Q · filed 2013-05-07 | |
| 2012-12-31 | 30.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | 30.25K shares 10-K · filed 2015-02-27 |
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | |
| 2011-12-31 | 5.20K shares 10-K · filed 2014-03-06 | |
| 2010-12-31 | 0.00 shares 10-K · filed 2013-03-18 | |
| 2009-12-31 | 53.37K shares 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |